Analyst Research Report Snapshot

Title:

Merck KGaA

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

08 Apr 2014

Pages:

54

Type:

AcrobatPDF

Companies referenced:

MRK.N

Available for Immediate Download
Summary:

Merck KGaA - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Merck KGaA required for business and competitor intelligence needs - A study of the major internal and external factors affecting Merck KGaA in the form of a SWOT analysis - An in-depth view of the business model of Merck KGaA including a breakdown and examination of key business segments - Intelligence on Merck KGaA’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Merck KGaA, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Merck KGaA (or 'the group') is a leader in pharmaceutical, chemical and life science. The group offers branded prescription drugs, and chemicals for high-tech applications. The Merck family holds an approximately 70% interest in the group and shareholders own the remaining approximately 30%. The group operates in 66 countries across the world. It is headquartered in Darmstadt, Germany and employed 38,847 people as of December 31, 2012. The group recorded revenues of E11,172.9 million ($14,366.1 million*) during the financial year ended December 2012 (FY2012), an increase of 8.7% over FY2011. The operating profit of the group was E963.6 million ($1,239 million*) in FY2012, a decrease of 14.9% over FY2011. The net profit was E566.7 million ($728.7 million*) in FY2012, a decrease of 6.6% over FY2011. *Calculated using a constant conversion rate of E1 = $1.2858 for the year ended December 31, 2012. Reasons to Purchase: - Gain understanding of Merck KGaA and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Merck KGaA as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Merck KGaA’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.